Breaking News Instant updates and real-time market news.

ABT

Abbott

$60.53

0.82 (1.37%)

, SRDX

Surmodics

$27.20

0.05 (0.18%)

09:04
02/27/18
02/27
09:04
02/27/18
09:04

Abbott and Surmodics announce agreement for SurVeil drug-coated balloon

Abbott (ABT) and Surmodics (SRDX) announced that the companies have entered into an agreement whereby Abbott will have exclusive worldwide commercialization rights for Surmodics' SurVeil drug-coated balloon to treat the superficial femoral artery, which is currently being evaluated in a U.S. pivotal clinical trial. Separately, Abbott also received options to negotiate agreements for Surmodics' below-the-knee and arteriovenous, or AV, fistula drug-coated balloon products, which are currently in pre-clinical development. As part of the agreement, Surmodics, a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, will supply the SurVeil drug-coated balloon to Abbott. The two companies will collaborate on product development, clinical trials and regulatory activities to obtain marketing approval in the U.S. and Europe.

ABT

Abbott

$60.53

0.82 (1.37%)

SRDX

Surmodics

$27.20

0.05 (0.18%)

ABT Abbott
$60.53

0.82 (1.37%)

02/27/18
JPMS
02/27/18
NO CHANGE
JPMS
Abbott's strong Libre launch supports cautious Dexcom stance, says JPMorgan
Abbott's Libre launch is off to a strong start in the U.S. with more than 25,000 patients having started on the device since the launch in early December, JPMorgan analyst Michael Weinstein tells investors in a research note. It remains way too early, however, to say what percent of patients will stick with the device, the analyst adds. The Libre launch reinforces the analyst's cautious stance on shares of Dexcom (DXCM). He expects Dexcom's growth to slow over the course of the year and for 2019 to prove "much more challenging" than 2018. Weinstein has an Overweight rating on Abbott and Neutral rating on Dexcom.
02/12/18
OPCO
02/12/18
NO CHANGE
Target $67
OPCO
Outperform
Dexcom price target lowered to $67 from $72 at Oppenheimer
Oppenheimer analyst Steven Lichtman lowered his price target for Dexcom (DXCM) to $67 from $72 on lowered estimates, while reiterating an Outperform rating on the stock. The analyst recently surveyed high-volume U.S. endocrinologists on the latest in continuous glucose monitoring now with Abbott's (ABT) Libre Flash on the market. According to respondents, there is some impact on Dexcom new prescriptions since Libre launch and some current Dexcom patients are interested in switching, but the impact looks within expectations, he contends. Overall, Lichtman believes the rollouts of Libre and Medtronic's (MDT) 670G remain overhangs on Dexcom near-term, but his survey suggests an environment no worse than guidance and conditions on the ground should change again in 2H18 with approval of Dexcom's next-generation G6.
01/30/18
ARGS
01/30/18
NO CHANGE
Target $80
ARGS
Buy
Abbott price target raised to $80 from $66 at Argus
Argus analyst David Toung raised his price target on Abbott to $80 and kept his Buy rating after strong Q4 top-line growth. Toung says the company's future expansion will be driven by the acquisitions of St. Jude Medical and Alere, as well as by the recent launch of new products, which merit a premium valuation.
01/30/18
PIPR
01/30/18
NO CHANGE
Target $60
PIPR
Overweight
Study shows superior outcomes for Dexcom over Abbott, says Piper Jaffray
Results of the I HART study that were published in the Diabetic Medicine journal showed superior outcomes for those on the Dexcom's (DXCM) G5 compared to Abbott's (ABT) Libre, Piper Jaffray analyst JP McKim tells investors in a research note. Specifically, G5 reduced time spent in hypoglycaemia both during the day and at night versus Libre that actually increased time, McKim adds. The analyst believes that while patients in the trial were ideal Dexcom candidates given their increased risk of hypoglycemia, the data can be used to differentiate the technology in the eyes of payers. He believes both G5 and Libre have a place in the system for different patient populations. The analyst keeps an Overweight rating on Dexcom with a $60 price target.
SRDX Surmodics
$27.20

0.05 (0.18%)

07/14/17
LSCM
07/14/17
INITIATION
Target $40
LSCM
Buy
Surmodics initiated with a Buy at Lake Street
Lake Street analyst Brooks O'Neil started Surmodics with a Buy rating and $40 price target. Positive news flow from the company's new product offerings should be a catalyst over the next few quarters, the analyst contends.
06/27/17
AGIS
06/27/17
INITIATION
Target $43.5
AGIS
Buy
SurModics initiated with a Buy at Aegis
Aegis analyst Benjamin Haynor initiated Surmodics with a Buy and a $43.50 price target saying the current pipeline has a dozen products seeking FDA 510 clearances as well as a third-generation drug-coated balloon platform which will require a PMA approval. He expects SurModics to seek partnering for each device and does not believe earnings power is appreciated by investors.

TODAY'S FREE FLY STORIES

02:20
07/17/18
07/17
02:20
07/17/18
02:20
General news
FX Update: The Dollar majors have been holding narrow ranges »

FX Update: The Dollar…

01:50
07/17/18
07/17
01:50
07/17/18
01:50
General news
Asian Market Wrap: »

Asian Market Wrap: Long…

01:45
07/17/18
07/17
01:45
07/17/18
01:45
General news
Breaking General news story  »

Federal Reserve Chairman…

PAA

Plains All American

$23.39

-0.14 (-0.59%)

20:30
07/16/18
07/16
20:30
07/16/18
20:30
Periodicals
Plains All American denied tariff exclusion in $1.1B project, Reuters says »

The U.S. Commerce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

COP

ConocoPhillips

$70.59

-1.425 (-1.98%)

20:13
07/16/18
07/16
20:13
07/16/18
20:13
Hot Stocks
ConocoPhillips provides 'strong' outlook for Alaska business »

ConocoPhillips provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

FSUMY

Fortescue Metal

$0.00

(0.00%)

20:08
07/16/18
07/16
20:08
07/16/18
20:08
Upgrade
Fortescue Metal rating change at Citi »

Fortescue Metal upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEP

PepsiCo

$112.95

0.23 (0.20%)

, DISH

Dish

$32.75

-0.84 (-2.50%)

20:02
07/16/18
07/16
20:02
07/16/18
20:02
Hot Stocks
PepsiCo to replace Dish in Nasdaq-100 index effective July 23rd »

Nasdaq announced that…

PEP

PepsiCo

$112.95

0.23 (0.20%)

DISH

Dish

$32.75

-0.84 (-2.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTW

Manitowoc

$26.99

-0.52 (-1.89%)

, CAT

Caterpillar

$138.06

-2.68 (-1.90%)

20:00
07/16/18
07/16
20:00
07/16/18
20:00
Downgrade
Manitowoc, Caterpillar, Deere, Generac rating change at Goldman Sachs »

Manitowoc downgraded to…

MTW

Manitowoc

$26.99

-0.52 (-1.89%)

CAT

Caterpillar

$138.06

-2.68 (-1.90%)

DE

Deere

$136.19

-1.41 (-1.02%)

GNRC

Generac

$52.40

-0.585 (-1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 08

    Aug

CZR

Caesars

$11.63

0.075 (0.65%)

19:33
07/16/18
07/16
19:33
07/16/18
19:33
Hot Stocks
Caesars breaks ground on $375M Caesars Forum in Las Vegas »

Caesars Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

19:25
07/16/18
07/16
19:25
07/16/18
19:25
Conference/Events
Morgan Stanley telecom analyst to hold an analyst/industry conference call »

U.S. Equity Strategist…

CAAP

Corporacion America Airport

$9.87

0.08 (0.82%)

19:11
07/16/18
07/16
19:11
07/16/18
19:11
Hot Stocks
Corporacion America Airport reports June passenger traffic up 5.8% »

Corporacion America…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIO

Rio Tinto

$53.64

-0.36 (-0.67%)

19:08
07/16/18
07/16
19:08
07/16/18
19:08
Hot Stocks
Rio Tinto announces Q2 Pilbara iron ore production 88.5Mt, up 14% from last year »

Pilbara iron ore…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

CDMO

Avid Bioservices

$4.46

-0.19 (-4.09%)

, IGT

International Game

$24.39

-0.5 (-2.01%)

19:06
07/16/18
07/16
19:06
07/16/18
19:06
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Avid…

CDMO

Avid Bioservices

$4.46

-0.19 (-4.09%)

IGT

International Game

$24.39

-0.5 (-2.01%)

BGS

B&G Foods

$29.80

-0.2 (-0.67%)

AG

First Majestic

$7.44

-0.265 (-3.44%)

NFLX

Netflix

$400.24

4.32 (1.09%)

ROKU

Roku

$48.27

-0.52 (-1.07%)

AVEO

Aveo Pharmaceuticals

$2.85

-0.055 (-1.90%)

EOLS

Evolus

$25.08

-1.12 (-4.27%)

TRQ

Turquoise Hill

$2.94

0.11 (3.89%)

CARB

Carbonite

$38.40

-0.1 (-0.26%)

RDFN

Redfin

$23.99

0.46 (1.96%)

NAKD

Naked Brand Group

$4.95

-0.15 (-2.94%)

MTW

Manitowoc

$26.99

-0.52 (-1.89%)

AMZN

Amazon.com

$1,822.02

9.02 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 17

    Jul

  • 18

    Jul

  • 26

    Jul

  • 02

    Aug

  • 02

    Aug

  • 16

    Aug

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

T

AT&T

$31.90

0.24 (0.76%)

18:58
07/16/18
07/16
18:58
07/16/18
18:58
Hot Stocks
Warner Bros.' 'Aquaman' film out in theaters December 21 »

Warner Bros.'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 09

    Aug

SBGI

Sinclair Broadcast

$29.10

-3.9 (-11.82%)

, TRCO

Tribune Media

$32.05

-6.55 (-16.97%)

18:57
07/16/18
07/16
18:57
07/16/18
18:57
Hot Stocks
Sinclair Broadcast 'shocked and disappointed' by FCC Chairman Pai's statement »

Sinclair Broadcast Group…

SBGI

Sinclair Broadcast

$29.10

-3.9 (-11.82%)

TRCO

Tribune Media

$32.05

-6.55 (-16.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 06

    Sep

DE

Deere

$136.19

-1.41 (-1.02%)

18:49
07/16/18
07/16
18:49
07/16/18
18:49
Downgrade
Deere rating change at Goldman Sachs »

Deere downgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$138.06

-2.68 (-1.90%)

18:49
07/16/18
07/16
18:49
07/16/18
18:49
Downgrade
Caterpillar rating change at Goldman Sachs »

Caterpillar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 08

    Aug

RIO

Rio Tinto

$53.64

-0.36 (-0.67%)

18:48
07/16/18
07/16
18:48
07/16/18
18:48
Hot Stocks
Rio Tinto says FY18 Pilbara shipments will be at upper end of prior forecast »

Rio Tinto states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

NFLX

Netflix

$400.24

4.32 (1.09%)

18:41
07/16/18
07/16
18:41
07/16/18
18:41
Hot Stocks
Breaking Hot Stocks news story on Netflix »

Netflix CEO: Still not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

NFLX

Netflix

$400.24

4.32 (1.09%)

18:39
07/16/18
07/16
18:39
07/16/18
18:39
Hot Stocks
Breaking Hot Stocks news story on Netflix »

Netflix says debt remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

IBM

IBM

$145.43

-0.48 (-0.33%)

, GRPN

Groupon

$4.70

0.025 (0.53%)

18:32
07/16/18
07/16
18:32
07/16/18
18:32
Periodicals
IBM seeks $166.5M in damages from Groupon in patent lawsuit, Bloomberg says »

IBM (IBM) is requesting…

IBM

IBM

$145.43

-0.48 (-0.33%)

GRPN

Groupon

$4.70

0.025 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

LGF.A

Lionsgate

$25.33

-0.58 (-2.24%)

, LGF.B

Lionsgate

$23.85

-0.69 (-2.81%)

18:30
07/16/18
07/16
18:30
07/16/18
18:30
Hot Stocks
Lionsgate announces Dr. John Malone, Scott Paterson to retire from board »

On July 11, Dr. John…

LGF.A

Lionsgate

$25.33

-0.58 (-2.24%)

LGF.B

Lionsgate

$23.85

-0.69 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

GNRC

Generac

$52.40

-0.585 (-1.10%)

18:30
07/16/18
07/16
18:30
07/16/18
18:30
Downgrade
Generac rating change at Goldman Sachs »

Generac downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTW

Manitowoc

$26.99

-0.52 (-1.89%)

18:29
07/16/18
07/16
18:29
07/16/18
18:29
Downgrade
Manitowoc rating change at Goldman Sachs »

Manitowoc downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$400.24

4.32 (1.09%)

18:27
07/16/18
07/16
18:27
07/16/18
18:27
Hot Stocks
Breaking Hot Stocks news story on Netflix »

Netflix CEO says median…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.